[Evaluation of the therapeutic activity of aminosidine, in inhalational administration, in chronic obstructive bronchopneumopathies].
D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001991:Bronchitis / Q000188:drug therapy; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010303:Paromomycin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012119:Respiration / Q000187:drug effects; D013183:Sputum / Q000382:microbiology
D010303:Paromomycin
Valutazione dell'attività terapeutica dell'amminosidina, somministrata per via inalatoria, nelle broncopneumopatie croniche ostruttive.